Rare disease specialist Ultragenyx reeled in a $14 million seed round for its Alzheimer’s gene therapy spinout Amlogenyx, the company exclusively told Endpoints News. …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
There was no difference in major post-operative complications in patients who continued vs. stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery, according to late-breaking research
Two emergency physicians allege that HCA Healthcare, owner of Mission Health in North Carolina, and staffing company TeamHealth have regularly overbilled government payers. In a
There are times when a new medical technology is thrust into the public spotlight because it seems like it might solve what we thought was